Details for Patent: 9,265,758

Which drugs does patent 9,265,758 protect, and when does it expire?

Patent 9,265,758 protects JUXTAPID and is included in one NDA.

This patent has twenty-seven patent family members in eighteen countries.

Summary for Patent: 9,265,758

Title:	Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
Abstract:	The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an effective amount of an MTP inhibitor to inhibit hyperlipidemia and/or hypercholesterolemia in said subject, wherein said administration comprises an escalating series of doses of the MTP inhibitor. In some embodiments the method comprises administering at least three step-wise, increasing dosages of the MTP inhibitor to the subject. In some embodiments, the method further comprises the administration of one or more other lipid modifying compounds.
Inventor(s):	Rader; Daniel J. (Philadelphia, PA)
Assignee:	The Trustees of the University of Pennsylvania (Philadelphia, PA)
Application Number:	14/075,483
Patent Claim Types: see list of patent claims	Use; Delivery;

Understanding the Scope and Claims of United States Patent 9,265,758: A Detailed Analysis

Introduction

United States Patent 9,265,758, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To analyze this patent, we need to delve into its various components and understand the broader patent landscape it operates within.

Patent Overview

United States Patent 9,265,758 is a specific patent that has been granted by the U.S. Patent and Trademark Office (USPTO). To begin, it is essential to identify the invention described in the patent, the claims that define the scope of the invention, and the background of the technology.

Invention Description

The invention described in the patent should be clearly outlined in the specification section. This section provides a detailed description of the invention, including its components, how it works, and any drawings or diagrams that illustrate the invention. Understanding the invention itself is crucial for analyzing its scope and claims.

Claims Analysis

The claims section of a patent is the most critical part as it defines the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more of the independent claims.

Independent Claims

Independent claims are broad and define the overall scope of the invention. They should be clear, concise, and fully describe the invention without referencing other claims.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations or features. These claims are often more specific and can provide additional protection by covering various aspects of the invention.

Subject Matter Eligibility

In the context of AI-related inventions, as highlighted by the 2024 USPTO guidance update, subject matter eligibility is a critical factor. The update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For example, claims that merely use abstract ideas or mathematical models without applying them in a specific, practical manner are generally not patent-eligible. However, claims that specify the use of these ideas in a real-world application, such as improving the accuracy of speech recognition systems, can meet the criteria for patent eligibility[1].

Determining Inventorship

Correctly determining who the true and only inventors are is paramount. US patent law requires that only the true inventors be listed on the patent application. Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable. Ensuring that all contributors to the conception and reduction to practice of the invention are properly identified is essential for maintaining the validity of the patent[5].

Patent Landscape

The patent landscape includes existing patents, published patent applications, and other relevant intellectual property. Tools like the USPTO's Public Search Facility and the Global Dossier service can help in searching for related patents and understanding the broader intellectual property environment.

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and access dossier, classification, and citation data[4].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers public access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users in their searches[4].

Economic and Research Implications

The economic and research implications of a patent can be significant. The USPTO's Patent Claims Research Dataset, for example, provides detailed information on claims from US patents and patent applications, which can be used to analyze trends and scope in patenting activities[3].

Real-World Applications

To bolster the argument for patent eligibility, it is crucial to highlight the real-world applications of the claimed method or system. Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is essential. For instance, in the context of AI, specifying the use of AI in a practical application such as enhancing speech recognition accuracy can make the claim patent-eligible[1].

Examples and Case Law

The 2024 USPTO guidance update includes examples specifically tailored to AI technologies. For example, Example 48 illustrates how claims involving the use of separated audio components in a speech recognition system can meet the eligibility criteria by demonstrating a practical application. This example underscores the importance of specifying the use of abstract ideas in real-world applications to ensure patent eligibility[1].

Key Takeaways

• Claims Analysis: The claims section is critical and must clearly define the scope of the invention.
• Subject Matter Eligibility: Ensuring that claims integrate judicial exceptions into practical applications is essential for patent eligibility.
• Inventorship: Correctly identifying the true and only inventors is vital for maintaining the validity of the patent.
• Patent Landscape: Understanding the broader intellectual property environment through tools like the Global Dossier and Public Search Facility is important.
• Real-World Applications: Highlighting the practical applications of the claimed invention is crucial for demonstrating patent eligibility.

FAQs

Q: What is the significance of the claims section in a patent? A: The claims section defines the scope of the invention and what is protected by the patent. It is the most critical part of the patent document.

Q: How does the 2024 USPTO guidance update impact AI-related inventions? A: The update clarifies the process for determining the patent eligibility of AI-related inventions by emphasizing the integration of judicial exceptions into practical applications.

Q: Why is correct inventorship important in patent applications? A: Correct inventorship is crucial because errors, especially those made with deceptive intent, can render the patent unenforceable.

Q: What tools are available for searching related patents and understanding the patent landscape? A: Tools such as the USPTO's Public Search Facility and the Global Dossier service are available for searching related patents and understanding the broader intellectual property environment.

Q: How can real-world applications impact the patent eligibility of an invention? A: Highlighting the real-world applications of the claimed method or system can demonstrate concrete benefits and solve specific problems, thereby making the claim patent-eligible.

Sources

1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
2. U.S. Patent and Trademark Office (USPTO) | USAGov.
3. Patent Claims Research Dataset - USPTO.
4. Search for patents - USPTO.
5. Determining Inventorship for US Patent Applications - Oregon State University.

Drugs Protected by US Patent 9,265,758

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-001	Dec 21, 2012		RX	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-002	Dec 21, 2012		RX	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-003	Dec 21, 2012		RX	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-004	Apr 23, 2015		RX	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-005	Apr 23, 2015		DISCN	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-006	Apr 23, 2015		DISCN	Yes	No	9,265,758					A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES

International Family Members for US Patent 9,265,758

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1725234		CA 2014 00002	Denmark
European Patent Office	1725234		C300634	Netherlands
European Patent Office	1725234		PA2014001	Lithuania
European Patent Office	1725234		C20140001 00107	Estonia
European Patent Office	1725234		14C0003	France
European Patent Office	1725234		1490006-2	Sweden
European Patent Office	1725234		92349	Luxembourg